|
HS Code |
290516 |
| Product Name | Pseudolaricis Cortex Veterinary Grade API |
| Dosage Forms | Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions |
| Active Ingredient | Pseudolaricis Cortex extract |
| Intended Use | Veterinary medicine |
| Appearance | Fine powder or crystalline form |
| Purity | ≥98% (by HPLC) |
| Solubility | Soluble in water and common organic solvents |
| Storage Conditions | Store in a cool, dry place away from light |
| Shelf Life | 24-36 months under recommended storage |
| Standard Compliance | Complies with veterinary pharmacopeia standards |
| Packaging | Sealed drums or bags, customizable upon request |
| Administration Route | Oral or injectable, depending on formulation |
As an accredited Pseudolaricis Cortex Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Sealed 25kg fiber drum with double-layer polyethylene liner, labeled “Pseudolaricis Cortex Veterinary API” for tablets, injections, capsules, and premix. |
| Shipping | The chemical **Pseudolaricis Cortex Veterinary Grade API** is securely packaged in sealed, pharmaceutical-grade containers, ensuring product integrity. Each package is labeled for traceability and shipped via certified carriers under temperature-controlled conditions when necessary. Express and bulk shipping options are available, complying with international regulations for safe and prompt delivery. |
| Storage | Pseudolaricis Cortex Veterinary Grade API should be stored in a tightly closed container, protected from moisture, light, and excessive heat. Keep in a cool, dry, and well-ventilated area, ideally at temperatures below 25°C. Avoid direct sunlight and sources of ignition. Store separately from incompatible substances and ensure the area is accessible only to qualified personnel. |
|
Purity 98%: Pseudolaricis Cortex Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Purity 98% is used in veterinary oral formulation development, where it ensures consistent therapeutic activity and reduces the risk of impurities. Particle Size D90<50 µm: Pseudolaricis Cortex Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Particle Size D90<50 µm is used in the production of fast-dissolving powder sachets for livestock, where it enhances dissolution rate and bioavailability. Moisture Content <1.5%: Pseudolaricis Cortex Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Moisture Content <1.5% is used in the manufacture of veterinary premixes, where it improves powder flowability and storage stability. Stability Up to 40°C: Pseudolaricis Cortex Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Stability Up to 40°C is used in injectable veterinary suspension formulations, where it maintains active ingredient potency under varied transport conditions. Assay ≥ 96% HPLC: Pseudolaricis Cortex Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Assay ≥ 96% HPLC is used in the compounding of sustained-release granules for animal health, where it assures precise dosage accuracy. Bulk Density 0.5–0.7 g/cm³: Pseudolaricis Cortex Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Bulk Density 0.5–0.7 g/cm³ is used in capsule filling operations, where it enhances capsule content uniformity and processing efficiency. pH Stability 4.5–7.5: Pseudolaricis Cortex Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with pH Stability 4.5–7.5 is used in liquid veterinary solution preparations, where it enables stable shelf life across standard formulation pH ranges. Melting Point 170–175°C: Pseudolaricis Cortex Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Melting Point 170–175°C is used in extrusion granulation processes, where it prevents thermal decomposition and preserves active efficacy. Residual Solvents <0.05%: Pseudolaricis Cortex Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with Residual Solvents <0.05% is used in veterinary injectable solutions, where it minimizes toxicological risks and meets regulatory limits. |
Competitive Pseudolaricis Cortex Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
At our plant, we turn years of hands-on experience with traditional extracts into reliable pharmaceutical-grade products for animal health. Pseudolaricis Cortex—extracted from the root bark of Pseudolarix amabilis—enters our production stream as carefully sourced, quality-screened botanical harvests. Our process puts consistency before everything else. Our veterinary grade API is designed for direct utility in tablets, injections, capsules, powders, granules, premix, and liquid solutions.
We take pride in direct knowledge of our raw materials, backed by careful vendor traceability and regular field audits. For finished API, we favor production infrastructure over contract manufacturing: this means full ownership from extraction to drying, granulation, and packaging. We skip uncertain shortcuts. Every batch reflects tight control, from the earliest wash to the final grind, checked by trained in-house labs.
Our Pseudolaricis Cortex stands apart because our team draws on practical expertise: we’ve actually handled every step ourselves, ensuring the final extract targets veterinary applications rather than broad, unfocused use. Pseudolaricis has drawn veterinary interest as a traditional agent against parasites, skin issues, and inflammatory conditions. Our focus lies in optimizing particle size and stability for the demands of veterinary production—leaving crude extracts and uneven blends behind.
Other Pseudolaricis products sometimes aim at herbal supplement markets, not veterinary medicine: we tune extraction, filtration, and drying to veterinary formulation—not loose powders or bulk herb sales. This includes close coordination with partner pharma labs to ensure our API works with most binding agents, solvents, and carriers common in animal meds. Too many products in the market skip the step of speaking with manufacturers of tablets, capsules, or injectable forms. We invite those teams into our process, aligning outcomes with industry needs.
We offer this API across a practical range of assays and mesh blends. Our veterinary line covers fine powders for direct tableting; free-flowing granules for mixing in premix or powdered feeds; injectable preparation grade, filtered and vacuum-dried for easy solubilization; capsule-ready materials with narrow particle ranges for uniform dosing; and high-concentration extracts for compact finished dose forms. Clients push us toward what works best in their manufacturing line, so we adapt models and specifications based on real dialogue—not based on generic guesses.
Our best-selling powder variant runs at a targeted concentration, balancing active principle (pseudolaric acid) at levels that suit veterinary pharmacopoeia. We adapt moisture limit, residual solvent, and total ash grade per order, in line with regulatory documents from different regions. For each batch, our analytics group monitors not just the typical markers (active principle content, microbial indicators, particle size by laser diffraction), but also runs pilot tablet and capsule batches in our own facility. This helps us understand flow behavior, binding, and dissolution. We never treat these as afterthoughts.
Customers value our approach because no batch leaves the factory before it runs through real formulation trials. Our team, working with local formulators, runs mock-up solids, suspensions, or liquid solution samples on-site, verifying that animal med processing—pressing, encapsulation, filling, or mixing—proceeds without blockage, caking, or layering. This practical, test bench work matters more than just numeric values on certificates. By the time you see our product, it’s had its feet in the real world—not just a laboratory fume hood.
For tablets, we zero in on even, fine particle size distribution to ensure quick mixing with common excipients like starch or MCC, and rapid press-fill. We avoid sticky or resinous byproducts by tuning the extraction and drying profile. Our flow agents and anti-caking process allow batch consistency tableting—a known pain point among veterinary API buyers pushing for higher line speed. Injectable API, typically a challenge with plant-based materials, benefits from our unique micronization sequence: filtered grade, low particulates, and tight control on residual insolubles. This means you get less clogging and lower risk during sterile filtration.
Capsule dosing requires batch uniformity. Our production historically battled variation in crude material—sometimes a problem with supply-side Pseudolaricis sources. We’ve solved this by sourcing from exclusive harvest regions, tightly timing our bark collection for consistent actives, and running continuous online monitoring during milling. Granules and premixes bring a different problem set: moisture, clumping, and solubility. We use multiple-point in-process checks for water activity and mesh cut, ensuring free movement through augers, bins, or bag fillers. These details are lost in mass-market extracts chasing generic herbal sales.
As a manufacturer, our R&D group works on improving repeatability in animal trials, reducing residue, and clarifying solubility for aqueous or oil-based injectable solutions. Past product development projects, typically joint piloting with animal health companies, have highlighted the importance of robust pilot batch records. Extracts often shift character based on season and regional source, so we run simultaneous multi-lot samplings—screening active component fluctuation and comparing with reference controls. Regular feedback means ongoing product improvement, often faster than government pharmacopoeia can update.
Pragmatism shapes our lot selection for repeat orders, not wishful promises or theoretical averages: we actively build feedback from animal medicine producers into each production round. Our on-site pilot equipment can handle test tablet pressing, capsule filling, and wet/dry injection load tests in parallel with extraction. This translates to quick response times for custom blends and better outcomes at the animal treatment end.
Complying with shifting veterinary guidelines across regions challenges manufacturers every season. We design our Pseudolaricis Cortex process documentation from harvest log to API batch release, adapting to the full spectrum of certificate, traceability, and data record demands—driven by experience with ASEAN, EU, North American, and African markets. Our documentation system evolved from years of regulatory audit and client input, not just cookbook SOP templates.
Veterinary regulators scrutinize origin and contamination status. We work from certified supply chains—never spot market purchases. Our records document every bark lot’s region, date, farming practice, and pesticide record. Processing lines run real-time environmental monitoring for microbials and cross contamination. Our QC system includes split sample archiving on-site for every lot released, giving us— and our customers—a clear backtrace if a query emerges post-shipment.
This tight management pays off during customer audits. Our process prints digital traceability for every kilogram produced, from kiln and extraction tank logs to packaging and storage data. Cultivating trusted documentation avoids interruptions to veterinary pipeline plans—most animal health buyers expect nothing less.
As direct hands-on manufacturers, we see the impact that careful process brings. Unlike traders, our investment in high-flow granulation, solvent extraction, freeze drying, and micronization directly feeds back into batch stability and repeat performance. Every production challenge—botanical resin content spiking, foaming during reconstitution, or sticky agglomerate in mixing—has a solution rooted in process adjustment, not wishing for better source material.
Having our own quality, processing, and packaging under one roof leads to faster cycles of improvement. Cutting out outsourcing means fresher, more active principle in each batch, tighter lead time, and less risk of cross-lot mistakes. If a client’s feedback notes odd behavior during processing or resizing, we trial new granulation runs within days, not weeks—cutting lag, saving time at the animal treatment level.
Many suppliers in this field rely on contractor extractors with little veterinary background. Their materials float between the supplement table and the drug screen, often lacking strict process records. Our staff, experienced with animal health, ground floor production, and hands-on veterinary R&D, forms our routine production meetings. This approach strengthens confidence among our customers. Reliability breeds more than regulatory compliance—it builds lasting relationships in a field where treatment outcomes matter.
Pseudolaricis Cortex has traditionally played a role in managing skin and parasitic disorders—especially in large animal integrative practice. We’ve seen its value in topical, oral, and injectable forms, particularly where synthetic antiparasitics run into resistance or withdrawal issues. Our API serves manufacturers producing finished veterinary products as diverse as small batch farm treatments, commercial swine and poultry powders, aquaculture antimicrobials, and small animal dermatology lines.
In the injection market, our clients demand clarity and predictable solubility. Formulation teams report fewer headaches working with our material; our extraction and drying remove insoluble plant debris, and micronization streamlines sterile filtration. Clients who move from generic Pseudolaricis powders to our finished API notice sharper batch consistency, better flow, and more predictable results in downstream formulations. For tablet and capsule uses, our powder and granule grades press and fill quickly, with less sticking and capping than coarse, resinous plant powders.
Powder and premix manufacturers care about blend-ability and reconstitution in water: here, our controlled mesh sizing and low moisture content give edge over steam-dried or sun-cured extracts, common in loosely controlled plants. Veterinary producers working with sensitive livestock—especially laying hens or milking herds—need confirmation of low pesticide, mycotoxin, and heavy metal content. Our batch records and lab tests track and publish these values, and our customers trust us because our operations keep contaminants out at every step.
The veterinary sector worldwide has raised its benchmarks for botanical APIs, thanks to ever-tighter residue regulations and the growing attention of animal owners. Our commitment to traceable raw materials, acute batch monitoring, pilot-process validation, and honest recordkeeping means every order delivers more than just a powder or solution. We put practical experience behind every pound: real plants, real process, and real results.
A decision to work with a direct manufacturer means gaining a transparent window into the full journey of every kilo shipped. We answer customer questions with specifics, not generic hand-waving. Our technical team backs up every delivery with know-how, from proper storage and reconstitution tips, to troubleshooting reactivity during formulation. Our knowledge base comes from actual usage, trial, and listening to what customers need—not just product literature.
The animal health world needs suppliers who are present on the factory floor and in the R&D lab, not just behind a desk. Every batch of Pseudolaricis Cortex API shipped from our facility shows that experience. It’s not the cheapest path—but it’s the one that brings results you can measure at the farm, the clinic, or the tableting line.
We believe in keeping science practical, not abstract—and in putting the facts and tools in your hands. Whether you manufacture tablets, capsules, injections, powders, granules, premixes, or solutions, our veterinary grade Pseudolaricis Cortex API brings reliability, transparency, and manufacturing know-how—from our factory to your finished product.